Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04752332
Status:
TERMINATED
Last Update Posted:
2024-05-29
First Post:
2021-02-11
Brief Title:
A Study of Abemaciclib LY2835219 Plus Hormone Therapy in Participants With Early Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-11
First Submit QC Date:
February 11 2021
Study First Post Date:
2021-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-24
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL